{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:11:58Z","timestamp":1791191518189,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.bbrc.2014.04.072","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T19:16:03Z","timestamp":1397934963000},"page":"678-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA"],"prefix":"10.1016","volume":"447","author":[{"given":"Miyuki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Hisanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.04.072_b0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2014.04.072_b0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(02)00299-1","article-title":"Lithium and valproic acid: parallels and contrasts in diverse signaling contexts","volume":"96","author":"Gurvich","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2014.04.072_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ntt.2012.08.005","article-title":"Alterations of neocortical development and maturation in autism: insight from valproic acid exposure and animal models of autism","volume":"36","author":"Chomiak","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.bbrc.2014.04.072_b0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentatory","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbrc.2014.04.072_b0025","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"39","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.072_b0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/mol.106.027078","article-title":"Chromatin remodeling: a novel mechanism of psychotropic drug action","volume":"70","author":"Newton","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.04.072_b0035","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ceb.2005.09.002","article-title":"Chromatin remodeling in neural development and plasticity","volume":"17","author":"Hsieh","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbrc.2014.04.072_b0040","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1158\/1078-0432.CCR-04-0395","article-title":"Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma","volume":"10","author":"Tang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2014.04.072_b0045","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/35096019","article-title":"A decade of CDK5","volume":"2","author":"Dhavan","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2014.04.072_b0050","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/biot.200700056","article-title":"The roles of cyclin-dependent kinase 5 in dendrite and synapse development","volume":"2","author":"Cheung","year":"2007","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.bbrc.2014.04.072_b0055","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1471-4159.2010.07050.x","article-title":"Regulation and role of cyclin-dependent kinase activity in neuronal survival and death","volume":"6","author":"Hisanaga","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2014.04.072_b0060","doi-asserted-by":"crossref","first-page":"24057","DOI":"10.1074\/jbc.273.37.24057","article-title":"P35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway","volume":"273","author":"Patrick","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.072_b0065","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1006\/bbrc.1998.9739","article-title":"Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons","volume":"252","author":"Saito","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.04.072_b0070","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1021\/bi100631f","article-title":"Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39","volume":"26","author":"Minegishi","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2014.04.072_b0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/35074516","article-title":"ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1","volume":"5","author":"Harada","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2014.04.072_b0080","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1074\/jbc.M805052200","article-title":"Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35","volume":"284","author":"Utreras","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.072_b0085","doi-asserted-by":"crossref","first-page":"11173","DOI":"10.1073\/pnas.93.20.11173","article-title":"Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death","volume":"93","author":"Ohshima","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2014.04.072_b0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/gtc.12029","article-title":"Extra-cell cycle regulatory functions of cyclin-dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders","volume":"18","author":"Kawauchi","year":"2013","journal-title":"Genes Cells"},{"key":"10.1016\/j.bbrc.2014.04.072_b0095","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nn1914","article-title":"Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation","volume":"10","author":"Hawasli","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2014.04.072_b0100","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/nn1943","article-title":"A hippocampal Cdk5 pathway regulates extinction of contextual fear","volume":"10","author":"Sananbenesi","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2014.04.072_b0105","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/nn.3237","article-title":"TrkB phosphorylation by Cdk5 is required for activity-dependent structural plasticity and spatial memory","volume":"15","author":"Lai","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2014.04.072_b0110","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.neuron.2014.01.022","article-title":"Memory enhancement by targeting Cdk5 regulation of NR2B","volume":"81","author":"Plattner","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2014.04.072_b0115","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1471-4159.2005.03058.x","article-title":"Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability","volume":"93","author":"Wei","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2014.04.072_b0120","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jnr.20975","article-title":"Enhanced activation of Ca2+\/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35","volume":"84","author":"Hosokawa","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbrc.2014.04.072_b0125","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.biopsych.2010.07.016","article-title":"Attention-deficit\/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35","volume":"12","author":"Drerup","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbrc.2014.04.072_b0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnbeh.2011.00056","article-title":"DARPP-32, Jack of all trades\u2026 master of which?","volume":"5","author":"Yger","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbrc.2014.04.072_b0135","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/brain\/awr155","article-title":"Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition","volume":"134","author":"Engmann","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2014.04.072_b0140","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1471-4159.2007.04505.x","article-title":"Cdk5-p39 is a labile complex with the similar substrate specificity to Cdk5-p35","volume":"102","author":"Yamada","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2014.04.072_b0145","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.23-04-01189.2003","article-title":"Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation","volume":"23","author":"Saito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2014.04.072_b0150","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1471-4159.2009.06385.x","article-title":"Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation","volume":"111","author":"Marinova","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2014.04.072_b9000","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainresbull.2011.03.006","article-title":"Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways","volume":"85","author":"Hu","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbrc.2014.04.072_b0155","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1523\/JNEUROSCI.20-16-06055.2000","article-title":"Integrin \u03b11\u03b21-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation","volume":"20","author":"Li","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2014.04.072_b0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-5618.2003.00031.x","article-title":"Valproate","volume":"5","author":"Bowden","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbrc.2014.04.072_b0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2009.05.002","article-title":"Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions","volume":"65","author":"Fukuchi","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbrc.2014.04.072_b0170","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/geno.1996.0370","article-title":"Molecular cloning and chromosomal mapping of the mouse gene encoding cyclin-dependent kinase 5 regulatory subunit p35","volume":"15","author":"Ohshima","year":"1996","journal-title":"Genomics"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14007141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14007141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T18:20:21Z","timestamp":1565374821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14007141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0006291X14007141"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.072","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}